Bausch Health Cos Net Income 2010-2024 | BHC

Bausch Health Cos net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Bausch Health Cos Annual Net Income
(Millions of US $)
2023 $-592
2022 $-225
2021 $-948
2020 $-560
2019 $-1,788
2018 $-4,148
2017 $2,404
2016 $-2,409
2015 $-292
2014 $881
2013 $-866
2012 $-116
2011 $160
2010 $-208
2009 $176
Bausch Health Cos Quarterly Net Income
(Millions of US $)
2024-09-30 $-85
2024-06-30 $10
2024-03-31 $-64
2023-12-31 $-39
2023-09-30 $-378
2023-06-30 $26
2023-03-31 $-201
2022-12-31 $-410
2022-09-30 $399
2022-06-30 $-145
2022-03-31 $-69
2021-12-31 $69
2021-09-30 $188
2021-06-30 $-595
2021-03-31 $-610
2020-12-31 $-153
2020-09-30 $71
2020-06-30 $-326
2020-03-31 $-152
2019-12-31 $-1,516
2019-09-30 $-49
2019-06-30 $-171
2019-03-31 $-52
2018-12-31 $-344
2018-09-30 $-350
2018-06-30 $-873
2018-03-31 $-2,581
2017-12-31 $513
2017-09-30 $1,301
2017-06-30 $-38
2017-03-31 $628
2016-12-31 $-515
2016-09-30 $-1,218
2016-06-30 $-302
2016-03-31 $-374
2015-12-31 $-386
2015-09-30 $50
2015-06-30 $-53
2015-03-31 $98
2014-12-31 $502
2014-09-30 $275
2014-06-30 $126
2014-03-31 $-23
2013-12-31 $124
2013-09-30 $-973
2013-06-30 $11
2013-03-31 $-28
2012-12-31 $-89
2012-09-30 $8
2012-06-30 $-22
2012-03-31 $-13
2011-12-31 $56
2011-09-30 $41
2011-06-30 $56
2011-03-31 $6
2010-12-31 $-31
2010-09-30 $-208
2010-06-30 $34
2010-03-31 $-3
2009-12-31 $73
2009-09-30 $40
2009-06-30 $24
2009-03-31 $39
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00